Offering

Kinetik Announces Secondary Offering of Common Stock

Retrieved on: 
Wednesday, March 13, 2024
Energy, Other Energy, Oil, Gas, BofA Securities, Mizuho Securities, 3rd Floor, J. P. Morgan, APA Corporation, Offering, Goldman Sachs, KNTK, Telephone, Sale, News, Broadridge Financial Solutions, File, ATTN:, Security (finance)

Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik” or the “Company”) announced today the commencement of an underwritten secondary offering of 11,373,801 shares of its Class A common stock (the “Offering”) by Apache Midstream LLC (the “Selling Stockholder”), a subsidiary of Apache Corporation.

Key Points: 
  • Kinetik Holdings Inc. (NYSE: KNTK) (“Kinetik” or the “Company”) announced today the commencement of an underwritten secondary offering of 11,373,801 shares of its Class A common stock (the “Offering”) by Apache Midstream LLC (the “Selling Stockholder”), a subsidiary of Apache Corporation.
  • Kinetik is not selling any shares of Class A common stock in the Offering and will not receive the proceeds from any sale of shares by the Selling Stockholder.
  • In connection with the Offering, the Selling Stockholder intends to grant to the underwriters a 30-day option to purchase up to an additional 1,706,070 shares of Kinetik’s Class A common stock.
  • In connection with the Offering, the Company’s Chief Executive Officer has provided an indication of interest in purchasing shares of Class A common stock from the underwriters at the public offering price.

Pagaya Announces Public Offering of Class A Ordinary Shares

Retrieved on: 
Wednesday, March 13, 2024
Technology, Finance, Security, Other Technology, Professional Services, Software, Internet, Data Management, Artificial Intelligence, Other Professional Services, Citigroup, Growth, Madison Avenue, Offering, Intelligence, Form, Telephone, Sale, Security (finance), Prospectus, Broadridge Financial Solutions, Jefferies, Jefferies Group, ATTN:, Keefe, Bruyette & Woods

Pagaya Technologies Ltd. (NASDAQ: PGY) (“Pagaya,” the “Company” or “we”), a global technology company delivering artificial intelligence infrastructure for the financial ecosystem, today announced that it has commenced an underwritten public offering (the “Offering”) of 6,500,000 Class A ordinary shares, no par value (“Class A Ordinary Shares”).

Key Points: 
  • Pagaya Technologies Ltd. (NASDAQ: PGY) (“Pagaya,” the “Company” or “we”), a global technology company delivering artificial intelligence infrastructure for the financial ecosystem, today announced that it has commenced an underwritten public offering (the “Offering”) of 6,500,000 Class A ordinary shares, no par value (“Class A Ordinary Shares”).
  • The Company intends to grant the underwriters a 30-day option to purchase up to 975,000 additional Class A Ordinary Shares.
  • The Company intends to use the net proceeds from the Offering for general corporate purposes and to support future growth, which may include working capital expenses and associated investments.
  • The Offering will be made only by means of a prospectus supplement and the accompanying prospectus.

REV Group, Inc. Announces Launch of Secondary Offering of Common Stock

Retrieved on: 
Wednesday, March 13, 2024
Trucking, Aftermarket, Automotive, General Automotive, Transport, Automotive Manufacturing, Manufacturing, Recreational Vehicles, Performance & Special Interest, REVG, Telephone, Offering, Form, REV Group, EDGAR, Sale, Attention, Security (finance), Morgan Stanley, Varick Street, Parallel, 2nd Floor

REV Group, Inc. (NYSE:REVG) (the “Company”) announced today the launch of an underwritten secondary public offering of 7,395,191 shares of the Company’s common stock (the “Offering”) by American Industrial Partners Capital Fund IV, LP and American Industrial Partners Capital Fund IV (Parallel), LP (the “Selling Stockholders”).

Key Points: 
  • REV Group, Inc. (NYSE:REVG) (the “Company”) announced today the launch of an underwritten secondary public offering of 7,395,191 shares of the Company’s common stock (the “Offering”) by American Industrial Partners Capital Fund IV, LP and American Industrial Partners Capital Fund IV (Parallel), LP (the “Selling Stockholders”).
  • The proposed offering is subject to market and other conditions, as well as customary closing conditions.
  • Goldman Sachs & Co. LLC and Morgan Stanley are acting as joint book-running managers for the Offering.
  • The underwriters intend to offer the shares of common stock to the public at a fixed price, which may be changed at any time without notice.

GE HealthCare Technologies Inc. Commences Secondary Offering of 13,000,000 Shares

Retrieved on: 
Tuesday, March 12, 2024
Professional Services, Health, Data Analytics, Hospitals, Health Technology, Other Health, Pharmaceutical, Offering, Communication, General Electric Company, Form, EDGAR, Sale, Attention, Prospectus, Morgan Stanley, GE HealthCare, Varick Street, 2nd Floor, Security (finance)

Prior to the closing of the Offering, General Electric Company (“GE”) is expected to exchange the GEHC Shares for indebtedness of GE held by Morgan Stanley Bank, N.A.

Key Points: 
  • Prior to the closing of the Offering, General Electric Company (“GE”) is expected to exchange the GEHC Shares for indebtedness of GE held by Morgan Stanley Bank, N.A.
  • Following the debt-for-equity exchange, if consummated, Morgan Stanley & Co. LLC, as the selling stockholder in the Offering, intends to sell the GEHC Shares to the underwriter in the Offering.
  • The selling stockholder in the Offering has granted the underwriter an option to purchase additional shares of GE HealthCare common stock for settlement on or before March 28, 2024.
  • The Offering will be made only by means of a free writing prospectus, the prospectus and the accompanying prospectus supplement relating to the Offering.

GE HealthCare Technologies Inc. Prices Upsized Secondary Offering of 14,000,000 Shares

Retrieved on: 
Wednesday, March 13, 2024
Professional Services, Health, Data Analytics, Hospitals, Health Technology, Other Health, Pharmaceutical, Offering, Communication, General Electric Company, Form, EDGAR, Sale, Attention, Prospectus, Morgan Stanley, Form S-3, GE HealthCare, Varick Street, 2nd Floor, Security (finance)

GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 14,000,000 shares of its common stock (the “GEHC Shares”).

Key Points: 
  • GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 14,000,000 shares of its common stock (the “GEHC Shares”).
  • The Offering was upsized from the previously announced offering size of 13,000,000 GEHC Shares.
  • GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for-equity exchange (as described below).
  • Prior to the closing of the Offering, General Electric Company (“GE”) is expected to exchange the GEHC Shares for indebtedness of GE held by Morgan Stanley Bank, N.A.

Aquaporin publishes prospectus and initiates rights issue

Retrieved on: 
Friday, April 5, 2024
Rights issue, Exercise, Prospectus, Nasdaq Copenhagen, Spar Nord, Water quality, AN, Regulation (European Union), NOT, Subscription business model, Finance Secretary (India), Senior, Offering, Executive, DKK, Water, Security (finance)

COPENHAGEN, Denmark, April 5, 2024 /PRNewswire/ -- Aquaporin A/S ("Aquaporin" or the "Company") (CSE: AQP) today announces that its board of directors (the "Board of Directors") has resolved to initiate a rights issue with pre-emptive subscription rights (the "Pre-emptive Rights") for the Company's existing shareholders allowing for subscription of up to 14,594,872 new shares with a nominal value of DKK 1 each (the "New Shares") at a subscription price of DKK 14 per New Share (the "Subscription Price") (the "Offering" or the "Rights Issue").

Key Points: 
  • : DK28315694
    COPENHAGEN, Denmark, April 5, 2024 /PRNewswire/ -- Aquaporin A/S ("Aquaporin" or the "Company") (CSE: AQP) today announces that its board of directors (the "Board of Directors") has resolved to initiate a rights issue with pre-emptive subscription rights (the "Pre-emptive Rights") for the Company's existing shareholders allowing for subscription of up to 14,594,872 new shares with a nominal value of DKK 1 each (the "New Shares") at a subscription price of DKK 14 per New Share (the "Subscription Price") (the "Offering" or the "Rights Issue").
  • A prospectus regarding the Offering (the "Prospectus") is, subject to certain restrictions, available at the Company's website: https://investors.aquaporin.com/investors/default.aspx .
  • Trades of Pre-emptive Rights executed during the Rights Trading Period will, however, not be affected.
  • Consequently, investors who have acquired Pre-emptive Rights will incur a loss corresponding to the purchase price of the Pre-emptive Rights and any transaction costs.

Abaxx Announces $10 Million Bought Deal Financing

Retrieved on: 
Monday, March 18, 2024
Indian stock exchange, NEO, Offering, Podcast, Regulation, BMO Capital Markets, Person, Security (finance)

The Offering is expected to close on or about March 28, 2024 and is subject to customary closing conditions, including receiving all necessary regulatory approvals.

Key Points: 
  • The Offering is expected to close on or about March 28, 2024 and is subject to customary closing conditions, including receiving all necessary regulatory approvals.
  • The Offering will be conducted pursuant to the Company's base shelf prospectus dated March 13, 2024 (the "Base Shelf Prospectus").
  • The Base Shelf Prospectus is currently available, and the Prospectus Supplement will be made available, under the Company's profile on SEDAR+  at www.sedarplus.ca .
  • This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States.

Burcon Closes Over-Subscribed $4.3 Million Non-Brokered Private Placement to Accelerate Commercial Plans

Retrieved on: 
Tuesday, March 12, 2024
Person, TSX, Sale, Multilateral, Indian stock exchange, Drink, Offering, Research, Security (finance)

Principal subscribers include Company directors, management, long-term shareholders, and new investors in support of Burcon's long-term vision.

Key Points: 
  • Principal subscribers include Company directors, management, long-term shareholders, and new investors in support of Burcon's long-term vision.
  • "We are excited to announce the successful completion of our private placement and combined with non-dilutive capital sources, fully funds our business plan to cash flow positive," said Kip Underwood, Burcon's chief executive officer.
  • "In response to significant customer interest for our protein offerings, we are accelerating our commercial plans.
  • All securities issued in connection with the Offering are subject to a statutory hold period in Canada expiring four months and one day from the closing of the private placement.

ME Therapeutics Announces Closing of Non-Brokered Private Placement

Retrieved on: 
Wednesday, March 6, 2024
News, Sale, Warrant, METX, Therapy, Unit, Acceleration, Cancer, Offering, Research, Security (finance)

Vancouver, British Columbia--(Newsfile Corp. - March 6, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, announces the closing of its previously announced non-brokered private placement financing (the "Offering") and has issued 1,555,000 units (each, a "Unit") at a price of $1.00 per Unit raising gross proceeds of $1,555,000.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - March 6, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, announces the closing of its previously announced non-brokered private placement financing (the "Offering") and has issued 1,555,000 units (each, a "Unit") at a price of $1.00 per Unit raising gross proceeds of $1,555,000.
  • Each Unit is comprised of one common share of the Company (each, a "Share") and one Share purchase warrant (each, a "Warrant").
  • All securities issued in connection with the Offering are subject to a statutory hold period expiring four months and one day after the date of the Closing.
  • No finder's fees were paid in connection with the Offering.

Cosa Resources Closes C$6.5 Million Private Placement

Retrieved on: 
Tuesday, March 5, 2024
TSX Venture Exchange, Person, Income Tax Act, News, Sale, Warrant, Multilateral, PI, CQS, Share (finance), Charity, Acceleration, LLP, Athabasca Basin, Minority, Unit, Offering, Security (finance)

Vancouver, British Columbia--(Newsfile Corp. - March 5, 2024) - Cosa Resources Corp. (TSXV: COSA) (OTCQB: COSAF) (FSE: SSKU) ("Cosa" or the "Company") is pleased to announce that it has closed the brokered private placement previously announced by the Company on February 12, 2024, as upsized on February 13, 2024, for aggregate gross proceeds of C$6,500,816 (the "Offering").

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - March 5, 2024) - Cosa Resources Corp. (TSXV: COSA) (OTCQB: COSAF) (FSE: SSKU) ("Cosa" or the "Company") is pleased to announce that it has closed the brokered private placement previously announced by the Company on February 12, 2024, as upsized on February 13, 2024, for aggregate gross proceeds of C$6,500,816 (the "Offering").
  • The Offering was completed through a syndicate of underwriters, led by Haywood Securities Inc. and including PI Financial Corp. (collectively, the "Underwriters").
  • All Qualifying Expenditures will be renounced in favour of the subscribers of the Charity FT Units effective December 31, 2024.
  • Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.